News
-
-
-
-
REGULATED PRESS RELEASE
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA -
-
-
-
-
PRESS RELEASE
Final Bell Holdings International Announces Revocation of Cease Trade Order and Closing of First Tranche of a US$12,000,000 Note Financing
Final Bell Holdings International Ltd. lifts cease trade order and closes first tranche of US$12 million convertible notes offering through subsidiary FBI for expansion in the United States -
PRESS RELEASE
Mission Hill Highlights Advanced Formulations for Modern Health Needs, Focusing on Women's Health
Mission Hill Foods introduces premium products targeting gut health, heart health, vision protection, and immune support. Focus on women's health, product quality, sustainability, and innovative research projects